Recently, K.Wang et al. demonstrated that the progression of thyroid carcinoma can be promoted by METTL3 and IGF2BP2 through m6A methylation on TCF1 mRNA and activation of Wnt signaling pathway in thyroid cancer [32]. The gene discussed is METTL3; the disease is thyroid gland carcinoma.